nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.576	1	CbGbCtD
Rosiglitazone—Haematocrit decreased—Riluzole—amyotrophic lateral sclerosis	0.0271	0.101	CcSEcCtD
Rosiglitazone—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0492	CcSEcCtD
Rosiglitazone—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0469	CcSEcCtD
Rosiglitazone—PPARG—forelimb—amyotrophic lateral sclerosis	0.011	0.164	CbGeAlD
Rosiglitazone—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0398	CcSEcCtD
Rosiglitazone—PPARG—hindlimb—amyotrophic lateral sclerosis	0.00992	0.148	CbGeAlD
Rosiglitazone—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00958	0.0358	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00898	0.0335	CcSEcCtD
Rosiglitazone—PPARG—appendage—amyotrophic lateral sclerosis	0.00851	0.127	CbGeAlD
Rosiglitazone—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00842	0.0314	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00838	0.0313	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00808	0.0302	CcSEcCtD
Rosiglitazone—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.0078	0.0291	CcSEcCtD
Rosiglitazone—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00751	0.028	CcSEcCtD
Rosiglitazone—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00576	0.0215	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00557	0.0208	CcSEcCtD
Rosiglitazone—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00553	0.0207	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00534	0.0199	CcSEcCtD
Rosiglitazone—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.0053	0.0198	CcSEcCtD
Rosiglitazone—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00507	0.0189	CcSEcCtD
Rosiglitazone—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00499	0.0186	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00498	0.0186	CcSEcCtD
Rosiglitazone—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00479	0.0179	CcSEcCtD
Rosiglitazone—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00474	0.0177	CcSEcCtD
Rosiglitazone—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.0047	0.0176	CcSEcCtD
Rosiglitazone—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00458	0.0171	CcSEcCtD
Rosiglitazone—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00441	0.0165	CcSEcCtD
Rosiglitazone—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00427	0.0159	CcSEcCtD
Rosiglitazone—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00408	0.0152	CcSEcCtD
Rosiglitazone—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00403	0.0151	CcSEcCtD
Rosiglitazone—ACSL4—medulla oblongata—amyotrophic lateral sclerosis	0.00402	0.0598	CbGeAlD
Rosiglitazone—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00395	0.0147	CcSEcCtD
Rosiglitazone—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00381	0.0142	CcSEcCtD
Rosiglitazone—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00376	0.014	CcSEcCtD
Rosiglitazone—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00376	0.014	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.0036	0.0134	CcSEcCtD
Rosiglitazone—Oedema—Riluzole—amyotrophic lateral sclerosis	0.0036	0.0134	CcSEcCtD
Rosiglitazone—ACSL4—spinal cord—amyotrophic lateral sclerosis	0.00358	0.0533	CbGeAlD
Rosiglitazone—Infection—Riluzole—amyotrophic lateral sclerosis	0.00358	0.0134	CcSEcCtD
Rosiglitazone—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00353	0.0132	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00353	0.0132	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00328	0.0122	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00311	0.0116	CcSEcCtD
Rosiglitazone—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.0031	0.0116	CcSEcCtD
Rosiglitazone—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00308	0.0115	CcSEcCtD
Rosiglitazone—ACSL4—nervous system—amyotrophic lateral sclerosis	0.00302	0.0449	CbGeAlD
Rosiglitazone—ACSL4—central nervous system—amyotrophic lateral sclerosis	0.0029	0.0432	CbGeAlD
Rosiglitazone—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00286	0.0107	CcSEcCtD
Rosiglitazone—ACSL4—cerebellum—amyotrophic lateral sclerosis	0.00284	0.0423	CbGeAlD
Rosiglitazone—PPARG—embryo—amyotrophic lateral sclerosis	0.00283	0.0421	CbGeAlD
Rosiglitazone—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00258	0.00965	CcSEcCtD
Rosiglitazone—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00951	CcSEcCtD
Rosiglitazone—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00246	0.0092	CcSEcCtD
Rosiglitazone—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00889	CcSEcCtD
Rosiglitazone—ACSL4—brain—amyotrophic lateral sclerosis	0.00231	0.0343	CbGeAlD
Rosiglitazone—Rash—Riluzole—amyotrophic lateral sclerosis	0.00227	0.00848	CcSEcCtD
Rosiglitazone—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00227	0.00847	CcSEcCtD
Rosiglitazone—Headache—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00842	CcSEcCtD
Rosiglitazone—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00799	CcSEcCtD
Rosiglitazone—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00199	0.0296	CbGeAlD
Rosiglitazone—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.0015	0.0223	CbGeAlD
Rosiglitazone—PPARG—nervous system—amyotrophic lateral sclerosis	0.00136	0.0202	CbGeAlD
Rosiglitazone—PPARG—central nervous system—amyotrophic lateral sclerosis	0.00131	0.0195	CbGeAlD
Rosiglitazone—CYP2A6—brain—amyotrophic lateral sclerosis	0.00122	0.0181	CbGeAlD
Rosiglitazone—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00114	0.0169	CbGeAlD
Rosiglitazone—PPARG—brain—amyotrophic lateral sclerosis	0.00104	0.0154	CbGeAlD
Rosiglitazone—ALB—brain—amyotrophic lateral sclerosis	0.000973	0.0145	CbGeAlD
Rosiglitazone—PTGS1—spinal cord—amyotrophic lateral sclerosis	0.000861	0.0128	CbGeAlD
Rosiglitazone—PTGS1—nervous system—amyotrophic lateral sclerosis	0.000726	0.0108	CbGeAlD
Rosiglitazone—PTGS1—central nervous system—amyotrophic lateral sclerosis	0.000699	0.0104	CbGeAlD
Rosiglitazone—CYP2C8—brain—amyotrophic lateral sclerosis	0.000684	0.0102	CbGeAlD
Rosiglitazone—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000596	0.00888	CbGeAlD
Rosiglitazone—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000574	0.00855	CbGeAlD
Rosiglitazone—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000561	0.00835	CbGeAlD
Rosiglitazone—PTGS1—brain—amyotrophic lateral sclerosis	0.000555	0.00826	CbGeAlD
Rosiglitazone—CYP2D6—brain—amyotrophic lateral sclerosis	0.000456	0.00679	CbGeAlD
Rosiglitazone—CYP2A6—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000229	0.00257	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000225	0.00252	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000217	0.00243	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000216	0.00242	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000215	0.00241	CbGpPWpGaD
Rosiglitazone—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000214	0.0024	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000213	0.00239	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000212	0.00238	CbGpPWpGaD
Rosiglitazone—PTGS1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000212	0.00238	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000211	0.00236	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000207	0.00232	CbGpPWpGaD
Rosiglitazone—CYP2A6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000201	0.00225	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000201	0.00225	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.0002	0.00224	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.0002	0.00224	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000198	0.00221	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000197	0.0022	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000195	0.00219	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000193	0.00216	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000193	0.00216	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000192	0.00215	CbGpPWpGaD
Rosiglitazone—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000191	0.00214	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000191	0.00214	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000189	0.00212	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000188	0.00211	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000188	0.0021	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000186	0.00209	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000186	0.00208	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000183	0.00205	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000183	0.00205	CbGpPWpGaD
Rosiglitazone—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000182	0.00204	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000179	0.00201	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000176	0.00197	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000171	0.00191	CbGpPWpGaD
Rosiglitazone—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.00017	0.00191	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000169	0.0019	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000169	0.00189	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000168	0.00189	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—DAO—amyotrophic lateral sclerosis	0.000168	0.00188	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000167	0.00188	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000164	0.00184	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000163	0.00183	CbGpPWpGaD
Rosiglitazone—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.000163	0.00183	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000163	0.00182	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000163	0.00182	CbGpPWpGaD
Rosiglitazone—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000163	0.00182	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000162	0.00182	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000162	0.00182	CbGpPWpGaD
Rosiglitazone—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.000157	0.00176	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000157	0.00176	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000156	0.00174	CbGpPWpGaD
Rosiglitazone—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000155	0.00174	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000155	0.00174	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000154	0.00173	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000154	0.00173	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000154	0.00172	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000152	0.0017	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00015	0.00168	CbGpPWpGaD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.00015	0.00168	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000149	0.00167	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000146	0.00164	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000145	0.00162	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.000142	0.00159	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000141	0.00158	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00014	0.00156	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000138	0.00155	CbGpPWpGaD
Rosiglitazone—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000137	0.00154	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000135	0.00152	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000135	0.00152	CbGpPWpGaD
Rosiglitazone—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000133	0.00149	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000132	0.00148	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000131	0.00147	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000131	0.00147	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00013	0.00146	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000129	0.00145	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000129	0.00144	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—APOE—amyotrophic lateral sclerosis	0.000128	0.00143	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000127	0.00143	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000126	0.00141	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000123	0.00138	CbGpPWpGaD
Rosiglitazone—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000122	0.00137	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000122	0.00137	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000121	0.00135	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000121	0.00135	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000118	0.00132	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—GSR—amyotrophic lateral sclerosis	0.000117	0.00132	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000115	0.00129	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.000114	0.00128	CbGpPWpGaD
Rosiglitazone—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000113	0.00126	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000112	0.00125	CbGpPWpGaD
Rosiglitazone—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000112	0.00125	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—DAO—amyotrophic lateral sclerosis	0.000111	0.00125	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000111	0.00125	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00011	0.00123	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000109	0.00122	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000107	0.0012	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000105	0.00118	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000105	0.00118	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000105	0.00118	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000105	0.00117	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000105	0.00117	CbGpPWpGaD
Rosiglitazone—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	0.000103	0.00115	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.000103	0.00115	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.0001	0.00112	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.8e-05	0.0011	CbGpPWpGaD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	9.78e-05	0.0011	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.75e-05	0.00109	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—CHAT—amyotrophic lateral sclerosis	9.65e-05	0.00108	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	9.61e-05	0.00108	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	9.56e-05	0.00107	CbGpPWpGaD
Rosiglitazone—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.54e-05	0.00107	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.41e-05	0.00105	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	9.38e-05	0.00105	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	9.38e-05	0.00105	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	9.27e-05	0.00104	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	9.27e-05	0.00104	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GSR—amyotrophic lateral sclerosis	9.25e-05	0.00104	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	9.05e-05	0.00101	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	8.99e-05	0.00101	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.94e-05	0.001	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	8.92e-05	0.001	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.89e-05	0.000996	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.8e-05	0.000987	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.75e-05	0.000981	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	8.75e-05	0.000981	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	8.63e-05	0.000967	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	8.63e-05	0.000967	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	8.58e-05	0.000962	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	8.56e-05	0.000959	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	8.56e-05	0.000959	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	8.43e-05	0.000945	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.42e-05	0.000944	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	8.4e-05	0.000942	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	8.36e-05	0.000937	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	8.26e-05	0.000926	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	8.25e-05	0.000925	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	8.23e-05	0.000922	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.98e-05	0.000894	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	7.98e-05	0.000894	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	7.89e-05	0.000885	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	7.82e-05	0.000877	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	7.78e-05	0.000872	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	7.6e-05	0.000852	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	7.6e-05	0.000852	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	7.56e-05	0.000847	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	7.5e-05	0.000841	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.49e-05	0.00084	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.34e-05	0.000823	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	7.31e-05	0.00082	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	7.31e-05	0.00082	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.27e-05	0.000815	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	6.97e-05	0.000782	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.93e-05	0.000777	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	6.9e-05	0.000773	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	6.84e-05	0.000767	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	6.82e-05	0.000764	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	6.78e-05	0.00076	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	6.76e-05	0.000758	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	6.69e-05	0.00075	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	6.39e-05	0.000716	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	6.24e-05	0.000699	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.22e-05	0.000697	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	6.19e-05	0.000693	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.17e-05	0.000691	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.03e-05	0.000676	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—MMP9—amyotrophic lateral sclerosis	5.92e-05	0.000664	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	5.89e-05	0.000661	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	5.84e-05	0.000655	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	5.76e-05	0.000646	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	5.73e-05	0.000642	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	5.32e-05	0.000596	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	5.32e-05	0.000596	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	5.29e-05	0.000593	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	5.29e-05	0.000593	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	5.29e-05	0.000592	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.18e-05	0.000581	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	5.14e-05	0.000576	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.84e-05	0.000543	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.81e-05	0.00054	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.76e-05	0.000534	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.75e-05	0.000532	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	4.74e-05	0.000532	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	4.73e-05	0.00053	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	4.69e-05	0.000525	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	4.55e-05	0.000511	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	4.36e-05	0.000489	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	4.36e-05	0.000489	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	4.34e-05	0.000487	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	4.33e-05	0.000485	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.32e-05	0.000484	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.22e-05	0.000474	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.08e-05	0.000458	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	4.01e-05	0.000449	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.98e-05	0.000446	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.96e-05	0.000444	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.94e-05	0.000442	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—APOE—amyotrophic lateral sclerosis	3.92e-05	0.000439	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	3.9e-05	0.000437	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.75e-05	0.000421	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	3.7e-05	0.000414	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.63e-05	0.000407	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	3.59e-05	0.000403	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	3.58e-05	0.000402	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.56e-05	0.000399	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	3.55e-05	0.000398	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.43e-05	0.000385	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.37e-05	0.000377	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.34e-05	0.000374	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.24e-05	0.000363	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.16e-05	0.000354	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—APOE—amyotrophic lateral sclerosis	3.09e-05	0.000346	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	3.04e-05	0.00034	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.77e-05	0.000311	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	2.75e-05	0.000308	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.73e-05	0.000306	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.71e-05	0.000304	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.69e-05	0.000301	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	2.6e-05	0.000291	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.44e-05	0.000273	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.35e-05	0.000263	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.35e-05	0.000263	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.33e-05	0.000261	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.22e-05	0.000249	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.16e-05	0.000242	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.14e-05	0.00024	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.12e-05	0.000237	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.09e-05	0.000235	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.93e-05	0.000216	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.92e-05	0.000216	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.91e-05	0.000214	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.9e-05	0.000213	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.88e-05	0.000211	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.78e-05	0.000199	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	1.77e-05	0.000199	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	1.77e-05	0.000199	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.77e-05	0.000198	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	1.76e-05	0.000198	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.75e-05	0.000197	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.63e-05	0.000183	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	1.58e-05	0.000177	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.5e-05	0.000168	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	1.46e-05	0.000163	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.44e-05	0.000162	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.23e-05	0.000138	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.22e-05	0.000136	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.21e-05	0.000135	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.08e-05	0.000122	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.98e-06	0.000112	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.89e-06	0.000111	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.45e-06	9.48e-05	CbGpPWpGaD
